$Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction$
QR Code

QR Code

Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction

Aim. To study the prognostic significance of cardiobiomarkers - NT-proBNP and soluble suppression of tumorigenecity (sST2) in patients with CHF with preserved (CHFpEF) and mildly reduced EF (CHFmrEF).Material and methods. Along with a clinical examination, 207 patients (111 men and 96 women), mean a...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. I. Podzolkov, N. A. Dragomiretskaya, A. V. Tolmacheva, I. I. Shvedov, A. A. Ivannikov, I. V. Akyol
Format:	Article
Language:	English
Published:	Столичная издательская компания 2023-10-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	sst2 heart failure with preserved ejection fraction heart failure with mildly reduced ejection fraction long-term survival
Online Access:	https://www.rpcardio.online/jour/article/view/2919
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

GALECTIN-3 AND NT-proBNP AS BIOMARKERS OF HEART FAILURE DECOMPENSATION
by: Yu. V. Dubolazova, et al.
Published: (2017-02-01)

Prediction model of rehospitalization and mortality in heart failure patients with preserved and mildly reduced ejection fraction: the AD2NNER risk score
by: Flavia-Mihaela Stoiculescu, et al.
Published: (2025-07-01)

Features of chronic heart failure depending on the left ventricular ejection fraction
by: A. G. Dushina, et al.
Published: (2019-03-01)

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01)

Correlation of β-adrenergic reactivity of erythrocyte membranes with clinical characteristics of patients with coronary artery disease and HF with preserved and reduced ejection fraction
by: E. F. Muslimova, et al.
Published: (2025-01-01)

Biomarkers in the Pathogenesis of Heart Failure with Preserved as Well as Reduced Ejection Fraction: A Cross-sectional Study
by: Sowmiya Thiyagarajan, et al.
Published: (2025-06-01)

Effect of therapy on the dynamics of collagen metabolism markers in older patients with heart failure with mid-range ejection fraction and coronary artery disease
by: O. A. Osipova, et al.
Published: (2020-11-01)

New possibilities in pharmacotherapy for the heart failure with reduced ejection fraction treatment in patients with recent deterioration
by: I. V. Gribkova
Published: (2024-03-01)

Features of structural and geometric remodeling of the heart and changes in the diastolic filling of the heart in patients with chronic heart failure of ischemic genesis with preserved left ventricular ejection fraction
by: V. A. Lysenko, et al.
Published: (2021-03-01)

Heart failure with preserved left ventricular ejection fraction – clinical perspectives
by: Małgorzata Niemiec, et al.
Published: (2025-07-01)

Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches
by: A. A. Shchendrygina, et al.
Published: (2021-07-01)

Molecular biomarker profile of heart failure with mid-range and preserved ejection fraction in patients with type 2 diabetes
by: D. A. Lebedev, et al.
Published: (2020-11-01)

Clinical and prognostic value of determining the level of neopterin in patients with chronic heart failure with preserved ejection fraction
by: O. S. Polunina, et al.
Published: (2018-10-01)

Results of the Russian Society of Cardiology survey "Chronic heart failure. Unsolved issues"
by: O. B. Irtyuga, et al.
Published: (2024-06-01)

Features of phenotyping patients with heart failure with preserved ejection fraction
by: E. K. Serezhina, et al.
Published: (2023-09-01)

About the classification of heart failure
by: A. S. Galyavich, et al.
Published: (2023-09-01)

Potential of NT-proBNP and sST2 rapid tests in patients with acute myocardial infarction
by: V. V. Ryabov, et al.
Published: (2023-07-01)

Characteristics of patients with chronic heart failure with mildly reduced ejection fraction: clinical and demographic aspect
by: M. T. Duishenalieva, et al.
Published: (2025-05-01)

Effect of Noncardiac Comorbidities on Quality of Life among Patients with Heart Failure - An Observational Study
by: J. Anusha, et al.
Published: (2025-07-01)

Lipoprotein(a) and Heart Failure Among Black and White Participants in Atherosclerosis Risk in Communities Study, Framingham Offspring Study, and Multi‐Ethnic Study of Atherosclerosis: The Pooling Project
by: Sarah Nomura, et al.
Published: (2025-06-01)

The impact of glomerular filtration rate on short-term outcome in elderly patients with heart failure with preserved ejection fraction
by: Giuseppe Delli Carpini, et al.
Published: (2025-07-01)

Markers of heart failure with preserved ejection fraction in patients with unexplained dyspnea
by: A. A. Ivanova, et al.
Published: (2023-11-01)

Endothelial Microvascular Dysfunction and Its Relationship with Haptoglobin Levels in Patients with Different Phenotypes of Chronic Heart Failure
by: V. I. Podzolkov, et al.
Published: (2021-11-01)

Low-intensity inflammation as a manifestation of comorbidity and a factor in the unfavorable clinical course of heart failure with preserved ejection fraction
by: K. N. Vitt, et al.
Published: (2024-03-01)

Cardiorenal relationships in patients with chronic heart failure with preserved ejection fraction
by: Yu. N. Panina, et al.
Published: (2023-11-01)

Electrocardiographic signs of impaired depolarization (fragmented QRS, early ventricular repolarization, etc.) as markers of left ventricular systolic dysfunction
by: M. S. Gordeeva, et al.
Published: (2022-08-01)

Cardiac remodeling in patients with heart failure with mildly reduced ejection fraction and metabolic disorders: association with biomarkers and autonomic nervous system parameters
by: E. A. Lyasnikova, et al.
Published: (2024-05-01)

Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible?
by: V. D. Zakiev, et al.
Published: (2023-12-01)

CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: TREATMENT IN CONDITIONS OF LIMITED EVIDENCE
by: S. G. KANORSKIĬ, et al.
Published: (2018-10-01)

Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement
by: S. N. Tereshchenko, et al.
Published: (2020-06-01)

Chronic Heart Failure with Preserved Ejection Fraction in A Comorbid Patient: Issues in Verification of A «Difficult» Diagnosis
by: O. V. Ponomareva, et al.
Published: (2025-05-01)

THE ROLE OF DIET AND PHYSICAL ACTIVITY IN THERAPY OF CARDIOVASCULAR PATIENTS WITH NORMAL EJECTION FRACTION
by: O. M. Drapkina, et al.
Published: (2017-04-01)

Microcirculation in heart failure: state of the art (literature review)
by: I. M. Davidovich, et al.
Published: (2025-02-01)

Prognostic value of atrial fibrillation in patients with heart failure and different left ventricular ejection fraction: results of the multicenter RIF-CHF register
by: I. V. Zhirov, et al.
Published: (2021-02-01)

Heart failure with improved ejection fraction in patients with tachycardia-induced cardiomyopathy: a case report
by: E. A. Pravkina, et al.
Published: (2023-07-01)

Clinical and anamnestic characteristics of patients depending on left ventricular ejection fraction: results of a register study
by: P. G. Parfenov, et al.
Published: (2024-07-01)

Prognostic significance of NT-proBNP and sST2 biomarkers in patients with post-myocardial infarction heart failure after a coronavirus infection
by: N. M. Kalashnikova, et al.
Published: (2023-07-01)

The Physical Activity in the Management of Heart Failure with Reduced Ejection Fraction A Review of Current Evidence and Recommendations
by: Natalia Smyl, et al.
Published: (2025-07-01)

Influence of intravenous ferric carboxymaltose on non-invasive parameters of left ventricular myocardial work in patients with heart failure with reduced ejection fraction
by: Zh. D. Kobalava, et al.
Published: (2023-02-01)

Possible risk factors for atrial fibrillation in patients with heart failure with mildly reduced ejection fraction
by: L. G. Azarapetyan, et al.
Published: (2024-04-01)